Gemcitabine, Cisplatin, and Nivolumab Facilitate Bladder Sparing in MIBC

Treatment with gemcitabine, cisplatin, and nivolumab facilitates bladder sparing in patients with muscle-invasive bladder cancer.

Related Keywords

New York , United States , Matthewd Galsky , , Icahn School Of Medicine At Mount Sinai , Healthday News , Icahn School , Mount Sinai ,